Abstract
In 1991, Soriano and coworkers isolated the ROSA26 locus in a gene-trap mutagenesis screening performed in mouse embryonic stem (ES) cells. The ubiquitous expression of ROSA26 in embryonic and adult tissues, together with the high frequency of gene-targeting events observed at this locus in murine ES cells has led to the establishment in the past 10 years of over 130 knock-in lines expressing successfully from the ROSA26 locus a variety of transgenes including reporters, site-specific recombinases and, recently, noncoding RNAs. Different strategies can be employed to drive transgene expression from the ROSA26 locus. This chapter provides an overview of the current methodologies used to generate ROSA26 knock-in lines and describes different approaches that exploit the ROSA26 gene to control expression of transgenes, including miRNAs, in a temporal, cell-type, and stage-specific fashion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. (1997) Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 94, 3789–3794.
Soriano P. (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21, 70–71.
Friedrich G, Soriano P. (1991) Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5, 1513–1523.
Niwa H, Yamamura K, Miyazaki J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193–199.
Xiao C, Calado DP, Galler G, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131,146–159.
Strathdee D, Ibbotson H, Grant SG. (2006) Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS One 1, e4.
Sasaki Y, Derudder E, Hobeika E, et al. (2006) Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729–739.
Beard C, Hochedlinger K, Plath K, Wutz A, Jaenisch R. (2006) Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44, 23–28.
Backman CM, Zhang Y, Malik N, et al. (2009) Generalized tetracycline induced Cre recombinase expression through the ROSA26 locus of recombinant mice. J Neurosci Methods 176, 16–23.
Schonig K, Schwenk F, Rajewsky K, Bujard H. (2002) Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 30, e134.
Hooper M, Hardy K, Handyside A, Hunter S, Monk M. (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326, 292–295.
Eggan K, Akutsu H, Loring J, et al. (2001) Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci USA 98, 6209–6214.
Tanimoto Y, Iijima S, Hasegawa Y, et al. (2008) Embryonic stem cells derived from C57BL/6J and C57BL/6N mice. Comp Med 58, 347–352.
Pettitt SJ, Liang Q, Rairdan XY, et al. (2009) Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat Methods 6, 493–495.
Seibler J, Kuter-Luks B, Kern H, et al. (2005) Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 33, e67.
Thai TH, Calado DP, Casola S, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316, 604–608.
Xiao C, Srinivasan L, Calado DP, et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9, 405–414.
Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP. (1999) Ubiquitous expression of marker transgenes in mice and rats. Dev Biol 214, 128–138.
Giel-Moloney M, Krause DS, Chen G, Van Etten RA, Leiter AB. (2007) Ubiquitous and uniform in vivo fluorescence in ROSA26-EGFP BAC transgenic mice. Genesis 45, 83–89.
Nyabi O, Naessens M, Haigh K, et al. (2009) Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells. Nucleic Acids Res 37, e55.
Tucker KL, Wang Y, Dausman J, Jaenisch R. (1997) A transgenic mouse strain expressing four drug-selectable marker genes. Nucleic Acids Res 25, 3745–3746.
Ramirez-Solis R, Rivera-Perez J, Wallace JD, Wims M, Zheng H, Bradley A. (1992) Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem 201, 331–335.
Chomczynski P. (1992) One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem 201, 134–139.
Acknowledgments
S. Casola is supported by the Giovanni Armenise/Harvard Career Development Award, the AIRC Foundation and by the European Research Council Starting Independent Researcher Grant, through the Italian Ministry of University and Research (progetto FIRB-IDEAS).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Casola, S. (2010). Mouse Models for miRNA Expression: The ROSA26 Locus. In: Monticelli, S. (eds) MicroRNAs and the Immune System. Methods in Molecular Biology, vol 667. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-811-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-811-9_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-810-2
Online ISBN: 978-1-60761-811-9
eBook Packages: Springer Protocols